Wolverine Trading’s Standard BioTools LAB Stock Holding History

Wolverine Trading’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$18K	Buy	+14,200	New	+$18.6K	﹤0.01%	5540
2021 Q4	–	Sell	-10,600	Closed	-$68K	–	6396
2021 Q3	$68K	Buy	+10,600	New	+$69.7K	﹤0.01%	5938
2021 Q2	–	Sell	-45,300	Closed	-$196K	–	6384
2021 Q1	$196K	Sell	45,300 -6,700	-13%	-$36.8K	﹤0.01%	5062
2020 Q4	$315K	Buy	52,000 +25,000	+93%	+$164K	﹤0.01%	3692
2020 Q3	$207K	Buy	+27,000	New	+$186K	﹤0.01%	3835
2016 Q3	–	Sell	-16,800	Closed	-$151K	–	4849
2016 Q2	$151K	Buy	+16,800	New	+$158K	﹤0.01%	3448

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Wolverine Trading's LAB Position: Q4 2024 in Review

Wolverine Trading sold out of Standard BioTools (LAB) in Q4 2024, closing a stake of 13,808 shares — an estimated $26.5K sold.

Wolverine Trading first reported a position in LAB in Q1 2017 and held it in 9 quarters. The position peaked at $382K in Q3 2020. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

Wolverine Trading reported no remaining Standard BioTools position as of Q4 2024 after selling out during the quarter.
Wolverine Trading sold 13,808 Standard BioTools shares in Q4 2024, an estimated $26.5K.
Wolverine Trading first reported a position in Standard BioTools in Q1 2017 and held it in 9 quarters.
Wolverine Trading's Standard BioTools position peaked at $382K in Q3 2020.
142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.